Skip to main content
Top

Social Determinants of Cardiovascular Health: Yes, They Matter—But What Can We Do to Address Them?

  • Open Access
  • 01-12-2026
  • Public Health Policy (SS Virani and D Mahtta, Section Editors)
Published in:

Abstract

Purpose of Review

Awareness of how social determinants of health (SDoH) shape cardiovascular outcomes is increasing, yet evidence on effective interventions remains limited. This review examines the associations between Healthy People 2030 SDoH domains and cardiovascular health (CVH), defined by the American Heart Association’s Life’s Essential 8 (LE8), and highlights interventions with potential to reduce disparities.

Recent Findings

Adverse SDoH—including economic instability, limited education and healthcare access, neighborhood disadvantage, and low social support—are consistently linked to lower LE8 scores and higher CVH burden, especially in under-resourced communities. Promising interventions include produce prescriptions, culturally tailored education, community health worker integration, built environment enhancements, and peer support models. However, most studies target single determinants, involve short follow-up, or focus on limited populations, leaving gaps in scalability and equity impact.

Summary

Addressing SDoH is essential for improving LE8 behaviors and factors. Progress requires multilevel, equity-centered strategies that align clinical care, policy, and research, while expanding rigorous trials to guide sustainable, community-driven solutions.
Title
Social Determinants of Cardiovascular Health: Yes, They Matter—But What Can We Do to Address Them?
Authors
Faith E. Metlock
Mathias Lalika
Joshua J. Joseph
Yvonne Commodore-Mensah
LaPrincess C. Brewer
Publication date
01-12-2026
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 1/2026
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-025-02336-2
This content is only visible if you are logged in and have the appropriate permissions.

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME